FHNGY yields 5.51% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, FHNGY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FHNGY + JNJ for your $10,000?
The Foschini Group Limited, together with its subsidiaries, operates independent chain-stores in South Africa and internationally. The company operates through TFG Africa Retail, Credit, TFG London, and TFG Australia segments. It offers clothing for men, ladies, and kids; jewelry; cellphones; accessories; cosmetics; sporting and outdoor apparel, and footwear and equipment; and homeware and furniture. The company provides its products under the @home, @homelivingspace, American Swiss, Archive, Connor, Donna, Exact, Fabiani, The FIX, Foschini, Galaxy & Co, G-Star RAW, Hi, Hobbs, Jet, Johnny Bigg, Markham, Phase Eight, Relay Jeans, RFO, Rockwear, Sneaker Factory, SODA Bloc, Sportscene, Sterns, Tarocash, Totalsports, Whistles, and yd. As of March 31, 2022, it operated 4,351 outlets in 26 countries. The company also offers its products online. The company was formerly known as Foschini Limited and changed its name to The Foschini Group Limited in September 2010. The Foschini Group Limited was founded in 1924 and is headquartered in Cape Town, South Africa.
Full FHNGY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.